PASG
Passage BIO, Inc.
Latest Form 4:Purchase$206KbyLynx1 Capital Management LP (10% Owner) · filed Jun 29, 2026
Passage BIO, Inc. (PASG) has 3 SEC Form 4 filings (5 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 29, 2026.
- Industry:Biotechnology
- CEO:William Chou
- Employees:24
- HQ:Philadelphia, PA, US
- IPO:2020-02-28
Insider Buying
$206K
reported purchases (SEC code P)
Insider Selling
$113K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$14.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 50,055 | $206K | Jun 29 | SEC ↗ | |
Chou WilliamFirst filing | PRESIDENT AND CEO | Sale | 4,076 | $75K | Jan 12 | SEC ↗ |
Borthwick KathleenFirst filing | CFO | Sale | 2,062 | $38K | Jan 12 | SEC ↗ |
Related companies
Passage BIO, Inc. is in the Healthcare sector.